Loading organizations...
§ Private Profile · Redwood City, CA, USA
Medical device company developing VisiPlate, a nanotechnology-enabled aqueous shunt for glaucoma treatment to reduce intraocular pressure.
Avisi Technologies is a Redwood City, California-based medical device startup that develops nanotechnology-enabled ocular implants to treat open-angle glaucoma and prevent irreversible vision loss. The clinical-stage company's flagship product, VisiPlate, is an ultrathin metamaterial aqueous shunt designed to reduce intraocular pressure by continuously draining excess fluid from within the human eye. Operating with a core team of eight full-time employees, the enterprise targets a domestic market of approximately 2.6 million patients currently suffering from aqueous misbalance. To date, the firm has secured over $7.5 million in venture capital and non-dilutive grant funding, backed by entities including Good Growth Capital, the National Science Foundation, and the MedTech Innovator accelerator. Avisi Technologies was founded in 2017 as an academic spin-out from the University of Pennsylvania by co-founders Rui Jing Jiang, Brandon Kao, and Adarsh Battu.
Avisi Technologies has raised $11.7M across 2 funding rounds.
Avisi Technologies has raised $11.7M in total across 2 funding rounds.
Avisi Technologies has raised $11.7M across 2 funding rounds. Most recently, it raised $10.7M Series A in February 2026.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 25, 2026 | $10.7M Series A | Justin Fukuyama | Accanto Partners, Gemseki, Golden Seeds, Good Growth Capital, Life Sciences Greenhouse OF Central Pennsylvania, Oneonefive, Quaker Capital Investments, SBI US Gateway Fund, Darren CAI | Announced |
| Sep 21, 2020 | $1M Grant | National Science Foundation | — | Announced |
Avisi Technologies has raised $11.7M in total across 2 funding rounds.
Avisi Technologies's investors include Justin Fukuyama, Accanto Partners, Gemseki, Golden Seeds, Good Growth Capital, Life Sciences Greenhouse of Central Pennsylvania, OneOneFive, Quaker Capital Investments, SBI US Gateway Fund, Darren Cai, National Science Foundation.